ArticleBiomacromolecules2018

Histone Deacetylase Inhibitor (HDACi) Conjugated Polycaprolactone for Combination Cancer Therapy.

Ruvanthi N Kularatne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.